RECRUITING

Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study formulates consensus agreement on clinical key elements related to prostate cancer care that are critical for standardization and global reported using a robust Delphi technique, completely remote and electronic. The goal of this survey study is to have a panel of specialty-specific experts create a consensus agreement on a minimum set of key data elements for use in standardized reports. These recommendations would be used to develop standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivorship.

Official Title

Key Elements for Standardized Reporting in Prostate Cancer Management: an Expert Delphi Consensus Study

Quick Facts

Study Start:2021-04-15
Study Completion:2026-05-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05054413

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 21 and above
  2. * Board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology
  3. * Maintenance of an active practice that includes prostate cancer patients
  4. * English speaking
  1. * Medical providers that are not board certified in the professions and/or those who do not treat prostate cancer
  2. * Prisoners, children, and adults unable to consent to participation will also be excluded
  3. * No exclusions were made based on sex, age, racial/ethnic background, or pregnancy status

Contacts and Locations

Study Contact

Amy C Moreno
CONTACT
713-745-4590
akmoreno@mdanderson.org

Principal Investigator

Amy C Moreno
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Amy C Moreno, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-04-15
Study Completion Date2026-05-01

Study Record Updates

Study Start Date2021-04-15
Study Completion Date2026-05-01

Terms related to this study

Additional Relevant MeSH Terms

  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm